UK national guideline for the management of gonorrhoea in adults, 2011

The British Association for Sexual Health and HIV (BASHH) UK gonorrhoea guideline has been updated in 2011. It offers advice on diagnosis, treatment and health promotion for anogenital and pharyngeal gonorrhoea. Nucleic acid amplification tests (NAATs) are now being used more for diagnosis and are increasing detection rates in the pharynx and rectum. First line treatment using ceftriaxone with azithromycin is now advised, along with routine test of cure (TOC). The aim is to slow the spread of resistant gonorrhoea now that fewer antibiotics remain effective. A patient information leaflet has been developed.

[1]  R. Echols,et al.  Single‐Dose Ciprofloxacin for the Treatment of Uncomplicated Gonorrhea: A Worldwide Summary , 1994, Sexually transmitted diseases.

[2]  S. Alexander.  The challenges of detecting gonorrhoea and chlamydia in rectal and pharyngeal sites: could we, should we, be doing more? , 2009, Sexually Transmitted Infections.

[3]  M. Unemo,et al.  Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae , 2009, Expert review of anti-infective therapy.

[4]  G. Wendel,et al.  Treatment of gonorrhea in pregnancy , 1993, Obstetrics and gynecology.

[5]  H. Mallinson,et al.  Evaluation of the Specificities of Five DNA Amplification Methods for the Detection of Neisseria gonorrhoeae , 2003, Journal of Clinical Microbiology.

[6]  C. Bignell.  Antibiotic treatment of gonorrhoea--clinical evidence for choice. , 1996, Genitourinary medicine.

[7]  J. Tapsall.  Current concepts in the management of gonorrhoea , 2002, Expert opinion on pharmacotherapy.

[8]  Charlotte A. Gaydos,et al.  Multicenter Evaluation of AMPLICOR and Automated COBAS AMPLICOR CT/NG Tests for Neisseria gonorrhoeae , 2000, Journal of Clinical Microbiology.

[9]  Charlotte A. Gaydos,et al.  Multicenter Evaluation of the BDProbeTec ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral Swabs , 2001, Journal of Clinical Microbiology.

[10]  H. Young,et al.  Azithromycin and erythromycin resistant Neisseria gonorrhoea e following treatment with azithromycin , 1997, International journal of STD & AIDS.

[11]  R. Ness,et al.  Systematic Review: Noninvasive Testing for Chlamydia trachomatis and Neisseria gonorrhoeae , 2005, Annals of Internal Medicine.

[12]  G. Ridgway,et al.  Chlamydia trachomatis and Neisseria gonorrhoeae infection and the sexual behaviour of men who have sex with men , 2006, Sexually Transmitted Infections.

[13]  M. Pichichero,et al.  Safe use of selected cephalosporins in penicillin-allergic patients: A meta-analysis , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  A. Katz,et al.  False-positive gonorrhea test results with a nucleic acid amplification test: the impact of low prevalence on positive predictive value. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  R. Desmond,et al.  Duration of Persistence of Gonococcal DNA Detected by Ligase Chain Reaction in Men and Women following Recommended Therapy for Uncomplicated Gonorrhea , 2002, Journal of Clinical Microbiology.

[16]  H. Mallinson,et al.  Finding, confirming, and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay , 2006, Sexually Transmitted Infections.

[17]  J. Zenilman,et al.  Therapy for gonococcal infections: options in 1989. , 1990, Reviews of infectious diseases.

[18]  W. Levine,et al.  Drugs of choice for the treatment of uncomplicated gonococcal infections. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  K. Radcliffe,et al.  The role of urethral samples in the diagnosis of gonorrhoea in women , 2004, International journal of STD & AIDS.

[20]  J. Moran.  Treating Uncomplicated Neisseria gonorrhoeae Infections: Is the Anatomic Site of Infection Important? , 1995, Sexually transmitted diseases.

[21]  T. Quinn,et al.  The Effect of Urine Testing in Evaluations of the Sensitivity of the Gen-Probe APTIMA®Combo 2 Assay on Endocervical Swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: The Infected Patient Standard Reduces Sensitivity of Single Site Evaluation , 2004, Sexually transmitted diseases.

[22]  R. Pattman,et al.  Audit of gonorrhoea test of cure at the genitourinary medicine department in Newcastle upon Tyne, UK , 2003, International journal of STD & AIDS.

[23]  D. Whiley,et al.  Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. , 2009, Journal of medical microbiology.

[24]  L. van Damme,et al.  Detection of Chlamydia trachomatis andNeisseria gonorrhoeae by Enzyme Immunoassay, Culture, and Three Nucleic Acid Amplification Tests , 2001, Journal of Clinical Microbiology.

[25]  J Sherrard,et al.  Gonorrhoea in men: clinical and diagnostic aspects. , 1996, Genitourinary medicine.

[26]  S. Chisholm,et al.  Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[27]  J. Tapsall,et al.  Ceftibuten Resistance and Treatment Failure of Neisseria gonorrhoeae Infection , 2008, Antimicrobial Agents and Chemotherapy.

[28]  E. Novak,et al.  Orally administered cefpodoxime proxetil for treatment of uncomplicated gonococcal urethritis in males: a dose-response study , 1992, Antimicrobial Agents and Chemotherapy.

[29]  C. Ison,et al.  European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. , 2006, The Journal of antimicrobial chemotherapy.

[30]  D. Livermore,et al.  Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? , 2010, The Journal of antimicrobial chemotherapy.

[31]  S. Richardson,et al.  Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture , 2009, Sexually Transmitted Infections.

[32]  K. Sankar,et al.  Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[33]  J M Kaldor,et al.  Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the Health in Men Study , 2006, Sexually Transmitted Infections.

[34]  E. Hook,et al.  Ability of New APTIMA CT and APTIMA GC Assays To Detect Chlamydia trachomatis and Neisseria gonorrhoeae in Male Urine and Urethral Swabs , 2005, Journal of Clinical Microbiology.

[35]  K. Workowski,et al.  Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment Guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  C. Bedford,et al.  National standards for the management of gonorrhoea , 1996, International journal of STD & AIDS.

[37]  P. Penney,et al.  Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations , 2011, International journal of STD & AIDS.

[38]  D. Livermore,et al.  Which cephalosporin for gonorrhoea? , 2004, Sexually Transmitted Infections.

[39]  John W Tapsall,et al.  Antibiotic resistance in Neisseria gonorrhoeae. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  J. Segreti.  Multicenter Trial of Single- Dose Azithromycin vs. Ceftriaxone in the Treatment of Uncomplicated Gonorrhea , 1994 .

[41]  古屋 隆三郎.  In vitro synergistic effects of double combinations of β-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae , 2008 .

[42]  B. Mulhall,et al.  Failure of Azithromycin Therapy in Gonorrhea and Discorrelation With Laboratory Test Parameters , 1998, Sexually transmitted diseases.

[43]  David H. Martin,et al.  Vaginal Swabs Are the Specimens of Choice When Screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results From a Multicenter Evaluation of the APTIMA Assays for Both Infections , 2005, Sexually transmitted diseases.

[44]  D. Whiley,et al.  Low positive predictive value of a nucleic acid amplification test for nongenital Neisseria gonorrhoeae infection in homosexual men. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  K. Workowski,et al.  Update on the management of gonorrhea in adults in the United States. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  D. Schlossberg,et al.  Multicenter Trial of Single‐Dose Azithromycin vs. Ceftriaxone in the Treatment of Uncomplicated Gonorrhea , 1994, Sexually transmitted diseases.

[47]  S. Garland,et al.  Exploring 'best practice' for nucleic acid detection of Neisseria gonorrhoeae. , 2008, Sexual health.

[48]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2006. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[49]  P. Brocklehurst.  Antibiotics for gonorrhoea in pregnancy. , 2002, The Cochrane database of systematic reviews.

[50]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[51]  J. Sheffield,et al.  A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. , 2001, American journal of obstetrics and gynecology.

[52]  S. Liska,et al.  Nucleic Acid Amplification Tests in the Diagnosis of Chlamydial and Gonococcal Infections of the Oropharynx and Rectum in Men Who Have Sex With Men , 2008, Sexually transmitted diseases.

[53]  A. Winston,et al.  Pharyngeal gonorrhoea – is dual therapy the way forward? , 2007, International journal of STD & AIDS.

[54]  I. Phillips,et al.  GONORRHŒA IN WOMEN Diagnostic, Clinical, and Laboratory Aspects , 1978, The Lancet.

[55]  C. Kent,et al.  Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  H. Korting,et al.  Effective Single Dose Treatment of Uncomplicated Gonorrhoea , 1994, International journal of STD & AIDS.

[57]  A. Jephcott.  Microbiological diagnosis of gonorrhoea. , 1997, Genitourinary medicine.

[58]  N. Low,et al.  Developing national outcome standards for the management of gonorrhoea and genital chlamydia in genitourinary medicine clinics , 2004, Sexually Transmitted Infections.